Here, we develop a new method for evaluating the phagocytic activity of CD206 macrophages in the BALF of patients with acute or chronic inflammation states (PCD, pneumonia or bronchial asthma). The gene discussed is MRC1; the disease is primary ciliary dyskinesia.